Cargando…

Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin

Gelation of pectin caused by divalent cations especially calcium ions has been applied to develop an ophthalmic formulation of azithromycin in the present study. Rapid elimination of drug on instillation into cul de sac would be minimal with in situ gelling ophthalmic solution leading to increased p...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijaya, C., Goud, K. Swetha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480745/
https://www.ncbi.nlm.nih.gov/pubmed/23112394
http://dx.doi.org/10.4103/0250-474X.100234
_version_ 1782247609819201536
author Vijaya, C.
Goud, K. Swetha
author_facet Vijaya, C.
Goud, K. Swetha
author_sort Vijaya, C.
collection PubMed
description Gelation of pectin caused by divalent cations especially calcium ions has been applied to develop an ophthalmic formulation of azithromycin in the present study. Rapid elimination of drug on instillation into cul de sac would be minimal with in situ gelling ophthalmic solution leading to increased precorneal contact time and prolonged drug delivery. In the formulation development studies pectin was used in different concentrations (1-5% w/v) and different proportions of the hydrocolloids hydroxypropyl methylcellulose and sodium carboxymethyl cellulose of different grades of viscosity were used. The primary criteria for formulation optimization were gelling capacity and rheological behaviour. In addition, formulations were evaluated for pH, and antimicrobial efficacy and drug release. The clarity, pH, gelation in simulated tear fluid and rheological properties of the optimized formulations were satisfactory. The formulations inhibited the growth of Staphylococcus aureus effectively in cup–plate method and were proved to be safe and non irritant on rabbit eyes. The results indicate that pectin based in situ gels can be successfully used to prolong the duration of action of azithromycin.
format Online
Article
Text
id pubmed-3480745
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34807452012-10-30 Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin Vijaya, C. Goud, K. Swetha Indian J Pharm Sci Research Paper Gelation of pectin caused by divalent cations especially calcium ions has been applied to develop an ophthalmic formulation of azithromycin in the present study. Rapid elimination of drug on instillation into cul de sac would be minimal with in situ gelling ophthalmic solution leading to increased precorneal contact time and prolonged drug delivery. In the formulation development studies pectin was used in different concentrations (1-5% w/v) and different proportions of the hydrocolloids hydroxypropyl methylcellulose and sodium carboxymethyl cellulose of different grades of viscosity were used. The primary criteria for formulation optimization were gelling capacity and rheological behaviour. In addition, formulations were evaluated for pH, and antimicrobial efficacy and drug release. The clarity, pH, gelation in simulated tear fluid and rheological properties of the optimized formulations were satisfactory. The formulations inhibited the growth of Staphylococcus aureus effectively in cup–plate method and were proved to be safe and non irritant on rabbit eyes. The results indicate that pectin based in situ gels can be successfully used to prolong the duration of action of azithromycin. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3480745/ /pubmed/23112394 http://dx.doi.org/10.4103/0250-474X.100234 Text en Copyright: © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Vijaya, C.
Goud, K. Swetha
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin
title Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin
title_full Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin
title_fullStr Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin
title_full_unstemmed Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin
title_short Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin
title_sort ion-activated in situ gelling ophthalmic delivery systems of azithromycin
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480745/
https://www.ncbi.nlm.nih.gov/pubmed/23112394
http://dx.doi.org/10.4103/0250-474X.100234
work_keys_str_mv AT vijayac ionactivatedinsitugellingophthalmicdeliverysystemsofazithromycin
AT goudkswetha ionactivatedinsitugellingophthalmicdeliverysystemsofazithromycin